Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Belgian Volition Srl (Be/Be) manages 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are split between 2 distinct examiners and 2 distinct art units, showing a distributed prosecution strategy.
NGUYEN, NAM P is the busiest examiner with 1 pending office action. With each examiner handling an action, the company's current workload is evenly partitioned across the identified art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, NAM P | 1 | 54.8% | +48.7% |
| SCHLOOP, ALLISON ELIZABETH | 1 | 63.3% | +47.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260018 | CIRCULATING TRANSCRIPTION FACTOR ANALYSIS | NGUYEN, NAM P | — |
| 18260011 | TRANSCRIPTION FACTOR BINDING SITE ANALYSIS OF NUCLEOSOME DEPLETED CIRCULATING CELL FREE CHROMATIN FRAGMENTS | SCHLOOP, ALLISON ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260018 | CIRCULATING TRANSCRIPTION FACTOR ANALYSIS | NGUYEN, NAM P | — |
| 18260011 | TRANSCRIPTION FACTOR BINDING SITE ANALYSIS OF NUCLEOSOME DEPLETED CIRCULATING CELL FREE CHROMATIN FRAGMENTS | SCHLOOP, ALLISON ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18260018 | CIRCULATING TRANSCRIPTION FACTOR ANALYSIS | NGUYEN, NAM P | 1678 | §101§102§103§112DP | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18260011 | TRANSCRIPTION FACTOR BINDING SITE ANALYSIS OF NUCLEOSOME DEPLETED CIRCULATING CELL FREE CHROMATIN FRAGMENTS | SCHLOOP, ALLISON ELIZABETH | 1682 | §101§103§112 | Non-Final OA | — | Pending | Jun 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBelgian Volition Srl (Be/Be) has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Nam P Nguyen has the most, with 1 of Belgian Volition Srl (Be/Be)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
